• Publications
  • Influence
Neurocognitive impairment in bipolar patients with and without history of psychosis.
OBJECTIVE Little is known regarding the impact of psychotic symptoms on the cognitive functioning of bipolar patients. Findings from previous reports are controversial and mainly focused on currentExpand
  • 151
  • 6
A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder.
OBJECTIVE To conduct the first randomized, controlled trial assessing the prophylactic efficacy of gabapentin in bipolar disorder. METHOD We conducted a 1-year, double-blind, randomized,Expand
  • 68
  • 3
Prevalence of cavum vergae in psychosis and mood spectrum disorders.
BACKGROUND Midline brain abnormalities might increase susceptibility to both first-episode and chronic mental disorder. Evidence of cavum vergae (CV) abnormality in mental disorders is scarce. Expand
  • 4
Differences between bipolar I and II patients regarding neurocognitive performance
Materials and methods A sample of 71 euthymic bipolar patients (38 bipolar I, 33 bipolar II), were included in the study. Euthymia was defined by a score of 6 or less at the Young Mania Rating Scale,Expand
  • 4